Atazanavir/Ritonavir Maintenance Therapy

Clinical Trial ID NCT00084019

Rank	Title	Journal	Year	PubWeight™‹?›
1	Maintenance therapy after quadruple induction therapy in HIV-1 infected individuals: Amsterdam Duration of Antiretroviral Medication (ADAM) study.	Lancet	1998	1.88
2	Maintenance antiretroviral therapies in HIV infected patients with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.	N Engl J Med	1998	1.88
3	A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.	N Engl J Med	1998	1.68
4	Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes.	J Infect Dis	2009	1.28
5	Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection.	AIDS	2004	1.17
6	Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression.	JAMA	2006	1.14
7	Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).	PLoS One	2014	0.75
8	Induction-maintenance antiretroviral strategies to reduce long-term toxicity.	J HIV Ther	2003	0.75